Zimbabwe: ARV Shortage: a Stitch in Time Saves Nine

[The Herald] Zimbabwe is among sub-Saharan African countries working tirelessly to meet the United Nations' 90-90-90 ambitious target to help end the HIV and Aids pandemic by 90 percent in 2020. On Monday, Zimbabweans woke up to news that seropositive people who are taking Abacavir -- a second line ARV drug -- are being given a week's supply of the drug instead of the traditional three months because of dwindled stocks.
Source: AllAfrica News: HIV-Aids and STDs - Category: Infectious Diseases Source Type: news